MA, G., NS, E., NA, M., EA, A., & SO, E. (2026). Retraction notice to "The α7 nAChR allosteric modulator PNU-120596 amends neuroinflammatory and motor consequences of parkinsonism in rats: Role of JAK2/NF-κB/GSk3β/ TNF-α pathway" [Biomedicine & Pharmacotherapy 148 (2022) 112776]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 198, 119234. https://doi.org/10.1016/j.biopha.2026.119234
Chicago Style (17th ed.) CitationMA, Gowayed, El-Sayed NS, Matar NA, Afify EA, and El-Ganainy SO. "Retraction Notice to "The α7 NAChR Allosteric Modulator PNU-120596 Amends Neuroinflammatory and Motor Consequences of Parkinsonism in Rats: Role of JAK2/NF-κB/GSk3β/ TNF-α Pathway" [Biomedicine & Pharmacotherapy 148 (2022) 112776]." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 198 (2026): 119234. https://doi.org/10.1016/j.biopha.2026.119234.
MLA (9th ed.) CitationMA, Gowayed, et al. "Retraction Notice to "The α7 NAChR Allosteric Modulator PNU-120596 Amends Neuroinflammatory and Motor Consequences of Parkinsonism in Rats: Role of JAK2/NF-κB/GSk3β/ TNF-α Pathway" [Biomedicine & Pharmacotherapy 148 (2022) 112776]." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 198, 2026, p. 119234, https://doi.org/10.1016/j.biopha.2026.119234.